IL5 and Increased total eosinophil count: Therefore, the inhibition of asthmatic symptoms by PS + CR may be associated with the reduction of IL-4 and IL-5 production and the eosinophilia aggregation into the lungs, as comparable to DEXA (3 mg/kg), at oral dose level of 1,000 mg/kg, once again.